Irinotecan combined with leucovorin-5-fluorouracil in the treatment of advanced colorectal cancer.

被引：0
|
作者：
Rigatos, SK [1 ]
Stathopoulos, GP [1 ]
Nacos, A [1 ]
Stathopoulos, J [1 ]
Pergantas, N [1 ]
Athanassiadis, I [1 ]
机构：
[1] Univ Athens, Dept Oncol, Hippokrat Hosp, Med Div 2, Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
246
引用
收藏
页码：56 / 56
页数：1
相关论文
共 50 条
  • [21] A phase II trial of irinotecan, 5-fluorouracil and leucovorin combined with celecoxib and glutamine as first-line therapy for advanced colorectal cancer
    Pan, CX
    Loehrer, P
    Seitz, D
    Helft, P
    Juliar, B
    Ansari, R
    Pletcher, W
    Vinson, J
    Cheng, L
    Sweeney, C
    ONCOLOGY, 2005, 69 (01) : 63 - 70
  • [22] Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
    Hurwitz, H
    Fehrenbacher, L
    Novotny, W
    Cartwright, T
    Hainsworth, J
    Heim, W
    Berlin, J
    Baron, A
    Griffing, S
    Holmgren, E
    Ferrara, N
    Fyfe, G
    Rogers, B
    Ross, R
    Kabbinavar, F
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23): : 2335 - 2342
  • [23] LACK OF EFFECTIVENESS OF COMBINED 5-FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH 5-FLUOROURACIL-RESISTANT ADVANCED COLORECTAL-CANCER
    VANGROENINGEN, CJ
    PETERS, GJ
    PINEDO, HM
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (01): : 45 - 49
  • [24] Leucovorin modulation of fluorouracil in advanced colorectal cancer
    deGramont, A
    Louvet, C
    Andre, T
    Tournigand, C
    Raymond, E
    Molitor, JL
    Krulik, M
    REVUE DE MEDECINE INTERNE, 1997, 18 : S372 - S378
  • [25] A pilot study of irinotecan combined with 5-fluorouracil and leucovorin (FOLFIRI) for the treatment of Chinese patients with locally advanced and metastatic gastric cancer
    Li, Q.
    Chen, J.
    Zhao, X.
    Yin, X.
    Mai, K.
    Chengya, Z.
    Cai, X.
    ANNALS OF ONCOLOGY, 2008, 19 : 43 - 43
  • [26] Bolus 5-fluorouracil plus leucovorin (FU-LV) in first-line treatment of advanced colorectal cancer.
    López, A
    Sánchez, J
    Gómez-Aldaraví, JL
    Fernández-Aramburo, A
    Yustos, A
    Romero, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S75 - S75
  • [27] OUR EXPERIENCE WITH IRINOTECAN AND BOLUS FLUOROURACIL/LEUCOVORIN IN THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
    Davidov, Deyan
    JOURNAL OF IMAB, 2009, 15 (01): : 49 - 52
  • [28] BEVACIZUMAB COMBINED WITH IRINOTECAN, 5- FLUOROURACIL AND LEUCOVORIN AS THE FIRST- LINE TREATMENT IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA
    Davidov, Deyan
    JOURNAL OF IMAB, 2014, 20 (06): : 556 - 559
  • [29] Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin in patients with advanced gastric cancer
    Sym, Sun Jin
    ANNALS OF ONCOLOGY, 2006, 17 : 315 - 315
  • [30] A phase II trial of irinotecan, 5-fluorouracil and leucovorin in patients with previously untreated advanced colorectal cancer (CRC)
    Lee, N.
    Bae, S.
    Lee, S.
    Kim, D.
    Kim, K.
    Kim, H.
    Kim, C.
    Lee, K.
    Won, J.
    Hong, D.
    Park, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345